Our Top Pick for more speculative investors is a biopharmaceutical company that discovers, develops, and commercializes oral antivirals in areas of unmet medical needs in the United States, explains Bill Mathews, editor of The Cheap Investor.
The lead product candidate from Chimerix (CMRX) is brincidofovir (CMX001), a nucleotide analog.
The drug is in Phase III clinical trials....More>>>
There’s been a lot of talk over the past few months about where Apple (NASDAQ:AAPL) may or may not expand its manufacturing footprint. President Trump would naturally like it if Apple brought some manufacturing jobs back home, despite the massive cost increases that would come along with such a move. But Apple has long faced challenges with expanding sales in India in part due to a government....More>>>
Longtime readers know Steve Sjuggerud is a true contrarian… Steve has made a career of recommending cheap, hated assets that most investors have no interest in owning… And he has a long track record of winners to show for it (including the best-performing recommendation in Stansberry Research history). But in last month's issue of his True Wealth Systems service,....More>>>
The government is about to unleash a controversial plan that will force many Americans to change the way they manage their retirement.
Dubbed the Obamacare of financial planning, this legislature is officially known as the fiduciary rule. And it has been touted as financial policy meant to serve in the best interest of investors, just like Obamacare was presented as health policy meant....More>>>
Social Security provides critical benefits to countless seniors and disabled Americans, but despite the program’s long-term standing, there has been talk in recent years of it running out of money. In fact, in a 2016 Transamerica survey, 77% of workers said they’re worried about Social Security going bankrupt by the time they’re set to retire.
U.S. stocks edged higher today, with five benchmark indices all closing at record levels as oil prices climbed higher.
It didnt take much to set those records. The S&P 500 jumped 16.29 points, or 0.75%, to close at 2,198.19. The Dow Jones Industrials ended at 18,956.83 after climbing 88.83 points, or 0.5%, and the Nasdaq Composite rallied 47.35 points, or 0.9%,....More>>>
Related TLT How Bond ETF Flows Affect ETF Sponsors Boring Bonds Boost ETF Asset Growth Related IWM Fast Money Picks For March 10 Fast Money Picks For March 8 Financial Risks: ECB Overstimulation (Seeking Alpha)
U.S. equities drifted lower on Thursday, risking a breakdown out of a tight two-month consolidation range just one day ahead of the inauguration of President-elect Donald Trump. This seems, on the surface, a little odd given Trump’s surprise victory boosted markets in a historic run to record highs.
But sentiment has turned recently, keeping the Dow Jones Industrial Average below....More>>>
I wrote bullishly about Deere (DE) back in December, and since then the stock has done…not much, gaining 4.8% to the S&P 500′s 4.1% rise. So I’ve tried to stay on top of the stock, both the bullish calls and the bearish ones–and today, I have another bear to add to the list. That would be JPMorgan’s Ann Duignan, who reiterated her Underweight rating on....More>>>
Singapore's largest property developer, CapitaLand (OTCPK:CLLDY) (CATL.SI) had a pretty good 2017. Helped by improving conditions in Singapore and China, not to mention significant project openings, CapitaLand's local shares climbed 20% and the ADRs did even better.
A power outage hit the CES consumer electronics show in Las Vegas, dimming the lights in one of the main convention halls hosting demonstrations from the likes of LG Electronics Inc. and Samsung Electronics Co.
“There is an isolated power outage at the Las Vegas Convention Center. W
In Lahore and Karachi, American flags were burned in front of TV cameras after President Trump’s decision on Jan. 4 to withhold $2 billion of security aid from Pakistan to punish it for allegedly harboring terrorists. The country’s government issued angry statements claiming no ins